CN101245072B - Intermediates for the preparation of prasugrel and methods for their preparation - Google Patents
Intermediates for the preparation of prasugrel and methods for their preparation Download PDFInfo
- Publication number
- CN101245072B CN101245072B CN2008100349958A CN200810034995A CN101245072B CN 101245072 B CN101245072 B CN 101245072B CN 2008100349958 A CN2008100349958 A CN 2008100349958A CN 200810034995 A CN200810034995 A CN 200810034995A CN 101245072 B CN101245072 B CN 101245072B
- Authority
- CN
- China
- Prior art keywords
- preparation
- prasugrel
- formula
- compound
- sodium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 0 *c1cc(CN(Cc2ccccc2)CC2)c2[s]1 Chemical compound *c1cc(CN(Cc2ccccc2)CC2)c2[s]1 0.000 description 1
Landscapes
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
The invention discloses a new intermediate of Prasugrel, the structural formula of which is shown as the figure. The preparation of the Prasugrel by adopting the intermediate of the invention has mild reaction condition and higher yield than that of an existing preparation method, and is economical and effective, thus being suitable for large-scale industrial production.
Description
Technical field
The present invention relates to a kind of intermediate and preparation method thereof technical field of prasugrel.
Background technology
Thrombus can make main organs generation ischemic and infraction, also can cause oedema and venous insufficiency, thereby causes various dysfunctions.Being used for clinical antithrombotic at present, to represent medicine be acetylsalicylic acid, clopidogrel and A Xi monoclonal antibody.The action intensity of clopidogrel is stronger than acetylsalicylic acid, side effect is little, clinical in-stent restenosis behind atheromatosis, acute coronary syndrome, the prevention coronary artery Stent and thrombotic complications etc. of being used for the treatment of.Prasugrel is and similar tetramethylene sulfide of clopidogrel and pyridine compounds and their that clinical three phases demonstrate activity, tolerance and the security that is better than clopidogrel, are expected to become a good antithrombotic reagent.The chemical name of prasugrel is: 2-acetoxyl group-5-(α-cyclopropyl carbonyl-2-luorobenzyl)-4,5,6, and the 7-tetramethylene sulfide is [3,2-c] pyridine also, and structural formula is as follows:
Chinese patent 92111584 discloses a kind of synthetic method of prasugrel, and its synthetic route is as follows:
This method is with 2-oxygen-2; 4; 5,6,7; 7 α-six hydrogen thieno-[3; 2-c] pyridine (formula 1 compound) and alpha-brominated adjacent luorobenzyl cyclopropyl ketone (formula 2 compounds) is raw material, reaction obtains 5-(α-cyclopropyl carbonyl-2-luorobenzyl)-2-oxygen-2,4 under alkaline condition; 5; 6,7,7a-six hydrogen thieno-s [3; 2-c] pyridine (formula 3 compounds); acidylate obtains 2-acetoxyl group-5-(α-cyclopropyl carbonyl-2-luorobenzyl)-4,5,6 then; the 7-tetramethylene sulfide is [3,2-c] pyridine (being prasugrel) also.
But the defective of aforesaid method is that formula (1) compound is as the important source material of preparation prasugrel, and not cheap industrial goods can be bought on market at present.And in U.S. Pat 470510 disclosed prior aries, its synthetic method is by 4,5,6,7-tetramethylene sulfide also [3,2-c] pyridine obtains 5-trityl-2-oxygen-2 with n-Butyl Lithium, tributyl borate reaction at low temperatures, 4,5,6,7 α-six hydrogen thieno-s [3,2-c] pyridine, last and formic acid react and obtain.Its reaction conditions is relatively harsher, needs-40 ℃ low temperature, and n-Butyl Lithium is inflammable and explosive simultaneously, can bring danger to scale operation.
In view of the good prospect in medicine of prasugrel, therefore need the intermediate of the preparation prasugrel of a kind of economy of exploitation, safety.
Summary of the invention
One of purpose of the present invention just provides a kind of new intermediate for preparing prasugrel, uses the synthetic prasugrel of this intermediate to overcome the above-mentioned defective of prior art, be very suitable for the big production of industry, and yield is than existing method height.
Another object of the present invention provides a kind of above-mentioned intermediates preparation.
The present inventor has found a kind of suitable prasugrel intermediate through a large amount of experiments, utilizes this intermediate to prepare prasugrel, not only stable reaction, yield height, and reaction conditions gentleness.Concrete technical scheme is as follows:
The intermediate of preparation prasugrel, the i.e. compound of following formula (IV):
Wherein X represents Cl or Br.
The intermediates preparation of above-mentioned preparation prasugrel comprises
Step 1: formula (I) compound and formula (II) compound react under alkaline condition
Obtain formula (III) compound,
Step 2: the halogenation of formula (III) compound obtains formula (IV) compound,
Wherein X represents Br or Cl.
Above-mentioned step 1, used solvent is well known by persons skilled in the art during reaction, comprises alcohol, ester class, methylene dichloride, tetrahydrofuran (THF), benzene, toluene, acetonitrile, DMF etc., preferred acetonitrile and DMF, more preferably DMF.Temperature of reaction is according to used solvent, and those skilled in the art can select best temperature range.Operable alkali comprises mineral alkali and organic bases, as yellow soda ash, salt of wormwood, sodium bicarbonate, sodium hydroxide, triethylamine, diisopropylethylamine etc., and preferred mineral alkali such as yellow soda ash, salt of wormwood etc.Can also add catalyzer such as sodium iodide, potassiumiodide etc. in addition.
Above-mentioned step 2 preferably uses hydrobromic acid solution and hydrogen peroxide as halogenating agent during halogenating reaction, also can use bromine as catalyzer.
Beneficial effect of the present invention: the present invention has found a kind of new prasugrel intermediate 2-bromo-5-benzyl-4,5,6, the 7-tetramethylene sulfide is [3,2-c] pyridine or 2-chloro-5-benzyl-4,5 also, 6, the 7-tetramethylene sulfide is [3,2-c] pyridine also, prepares prasugrel with it, the reaction conditions gentleness, and yield is than prior preparation method height, and economical and effective is suitable for large-scale industrial production.
Embodiment
Preferred embodiment with concrete operations with reference to the following examples.
Embodiment 1~2
5-benzyl-4,5,6,7-tetramethylene sulfide be the preparation of [3,2-c] pyridines (formula III) also:
With 4,5,6,7-tetramethylene sulfide also [3,2-c] pyridines (7.0g), salt of wormwood (7.2g) mixes with acetonitrile (50ml), adds Benzyl Chloride (6.1g), stirs after 0.5 hour and refluxes 3 hours.Cooling is filtered, and filtrate is concentrated into dried, add ethyl acetate (30ml) and water (50ml), separatory, water layer extracts with ethyl acetate (30ml * 2), merge organic layer, washing, drying, be concentrated into the dried title compound 5-benzyl-4 that obtains, 5,6,7-tetramethylene sulfide also [3,2-c] pyridine 8.3g, yield 90.8%.
4,5,6,7-tetramethylene sulfide also [3,2-c] pyridine (18.0g), salt of wormwood (18.6g), Benzyl Chloride (15.0g), sodium iodide (0.8g) stir in DMF (100ml) after 0.5 hour in 80 ℃ of reactions 3 hours, and cooling adds entry (150ml) and ethyl acetate (100ml), separatory, water layer extracts with ethyl acetate (50ml * 2).Merge organic layer, washing, drying is concentrated into dried title compound 23.2g, yield 98.7%.
Embodiment 3
2-bromo-5-benzyl-4,5,6, the 7-tetramethylene sulfide is the preparation of [3,2-c] pyridines (formula IV) also:
The compound (23.2g) that embodiment 2 is obtained is dissolved in acetic acid (100.0ml), 40% Hydrogen bromide (75.0ml), the methyl alcohol (100ml), and the ice-water bath cooling drips methyl alcohol (100ml) solution of 30% hydrogen peroxide (33.0ml), stirring at room 3 hours down.Drip hypo solution (150ml), dripping saturated sodium carbonate solution again is 9 to pH, and methylene dichloride (100ml * 3) extracts, and merges organic layer, washing, and drying is concentrated into dried light yellow solid 30.5g, yield 97.8%.
Embodiment 4
2-methoxyl group-5-benzyl-4,5,6,7-tetramethylene sulfide be the preparation of [3,2-c] pyridine also:
Sodium (24.0g) is dissolved in methyl alcohol (350ml), is concentrated into driedly, add dioxane (300ml), 2-bromo-5-benzyl-4,5,6, the 7-tetramethylene sulfide is [3,2-c] pyridines (30.5g), cuprous bromide (1.5g) and sodium iodide (0.8g) also, stirring and refluxing 16 hours.Cooling, filter and use methanol wash, filtrate is concentrated into dried, add ethyl acetate (150ml) and water (250ml), separatory, water layer extracts with ethyl acetate (100ml * 2), merge organic layer, disodium ethylene diamine tetra-acetic acid solution (100ml * 2), salt solution (100ml * 3) are washed, and drying is concentrated into dried oily matter 29.3g.Add ethyl acetate (200ml), the ethanolic soln pH that drips hydrogenchloride is 1, and ice-water bath stirred 1 hour, filters and washes with ethyl acetate, dry light yellow solid 24.0g, yield 82.2%.
Embodiment 5
2-methoxyl group-4,5,6,7-tetramethylene sulfide be the preparation of [3,2-c] pyridine hydrochloride also:
With 2-methoxyl group-5-benzyl-4,5,6,7-tetramethylene sulfide also [3,2-c] to regulate pH be 12 to pyridine hydrochloride (20.0g) hydro-oxidation sodium solution, extracts with ethyl acetate (150ml * 3), merges organic layer, water (100ml * 3) is washed, and drying is concentrated into dried oily matter.Add toluene (240ml), diisopropylethylamine (26.5ml) and phenyl chloroformate (20ml), 70 ℃ of stirring reactions 2 hours.Cooling adds saturated sodium bicarbonate solution (180ml), layering, and organic layer is used salt solution (120ml) washing again with saturated sodium bicarbonate (120ml * 2) washing.Organic layer is concentrated into dried, adds the inferior maple (120ml) of diformazan, sodium hydroxide (12g) and water (18ml), 70 ℃ of stirring reactions 12 hours.Cooling adds frozen water (350ml), and it is 9 that the hydro-oxidation sodium solution is regulated pH.Extract with methylene dichloride (150ml * 3), washing, drying is concentrated into dried oily matter 27.5g.(200ml) dissolving that adds diethyl ether, it is 3 that the diethyl ether solution that drips hydrogenchloride is regulated pH, ice-water bath stirred 1 hour, filtered and washed with ether, dry light yellow solid 11.2g, yield 80.3%.
Embodiment 6
2-methoxyl group-5-(α-cyclopropyl carbonyl-2-luorobenzyl)-4,5,6, the 7-tetramethylene sulfide is the preparation of [3,2-c] pyridine hydrochloride also:
With 2-methoxyl group-4,5,6, the 7-tetramethylene sulfide also [3,2-c] pyridine hydrochlorides (1.25g) hydro-oxidation sodium solution to regulate pH be 12, extract with methylene dichloride (15ml * 3), merge organic layer, water (10ml * 2) is washed, drying is concentrated into dried oily matter.Add the adjacent luorobenzyl cyclopropyl ketone (1.42g) of alpha-chloro, salt of wormwood (1.01g), sodium iodide (0.1g) and acetonitrile (30ml), refluxed 3 hours, cooling is filtered and is washed with acetonitrile.Filtrate is concentrated into dried, adds water (50ml), extracts with ethyl acetate (30ml * 3), merges organic layer, washing, and drying is concentrated into dried oily matter 2.5g.(50ml) dissolving that adds diethyl ether, it is 3 that the diethyl ether solution that drips hydrogenchloride is regulated pH, ice-water bath stirred 1 hour, filtered and washed with ether, dry light yellow solid 2.15g, yield 92.6%.
Embodiment 7
5-(α-cyclopropyl carbonyl-2-luorobenzyl)-2-oxygen-2,4,5,6,7, the preparation of 7a-six hydrogen thieno-s [3,2-c] pyridine hydrochloride:
2-methoxyl group-5-(α-cyclopropyl carbonyl-2-luorobenzyl)-4,5,6,7-tetramethylene sulfide also [3,2-c] pyridine hydrochlorides (2.15g), 1M hydrochloric acid (20ml) reacted 3 hours in 80 ℃.Cooling, with the sodium carbonate solution neutralization, ethyl acetate (30ml * 3) is extracted, and merges organic layer, and water (10ml * 2) is washed, and drying is concentrated into dried.(50ml) dissolving that adds diethyl ether, it is 3 that the diethyl ether solution that drips hydrogenchloride is regulated pH, ice-water bath stirred 1 hour, filtered and washed with ether, dry light yellow solid 1.55g, yield 74.8%.
Embodiment 8
2-acetoxyl group-5-(α-cyclopropyl carbonyl-2-luorobenzyl)-4,5,6, the 7-tetramethylene sulfide is the preparation of [3,2-c] pyridine hydrochloride (being prasugrel) also:
5-(α-cyclopropyl carbonyl-2-luorobenzyl)-2-oxygen-2,4,5,6,7,7a-six hydrogen thieno-s [3,2-c] pyridine hydrochlorides (0.3g), adding sodium carbonate solution adjusting pH value is 7~8, extract with ethyl acetate (15ml * 3), merge organic layer, water (10ml * 2) is washed, drying, is concentrated into dried.Add N, dinethylformamide (2ml), acetic anhydride (1ml), the frozen water cooling adds 60% sodium hydrogen (0.1g), stirring at room 3 hours.Add ethyl acetate (40ml), salt solution (10ml * 3) is washed, and drying is concentrated into dried.(20ml) dissolving that adds diethyl ether, it is 3 that the diethyl ether solution that drips hydrogenchloride is regulated pH, ice-water bath stirred 1 hour, filtered and washed with ether, dry white solid 0.22g, yield 65.8%.
Claims (8)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100349958A CN101245072B (en) | 2008-03-21 | 2008-03-21 | Intermediates for the preparation of prasugrel and methods for their preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100349958A CN101245072B (en) | 2008-03-21 | 2008-03-21 | Intermediates for the preparation of prasugrel and methods for their preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101245072A CN101245072A (en) | 2008-08-20 |
| CN101245072B true CN101245072B (en) | 2011-03-30 |
Family
ID=39945778
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008100349958A Expired - Fee Related CN101245072B (en) | 2008-03-21 | 2008-03-21 | Intermediates for the preparation of prasugrel and methods for their preparation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101245072B (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101402556B (en) * | 2008-11-11 | 2014-01-29 | 上海现代制药股份有限公司 | Novel compound 1-cyclopropyl-2-(2-fluorophenyl)-2-hydroxyethanone and its preparation method and use |
| HU229035B1 (en) | 2009-12-21 | 2013-07-29 | Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag | Process for producing prasurgel |
| HU229031B1 (en) | 2009-12-21 | 2013-07-29 | Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag | Process for producing prasurgel and its intermediate |
| CN101830911B (en) * | 2010-06-11 | 2012-05-09 | 天津药物研究院 | Thienopyridine derivatives, preparation method and application thereof |
| HUP1000565A2 (en) | 2010-10-22 | 2012-05-02 | Egis Gyogyszergyar Nyrt | Process for the preparation of pharmaceutically active compound and intermediers |
| CN102002056B (en) * | 2010-11-02 | 2012-04-25 | 北京赛科药业有限责任公司 | Preparation method of prasugrel intermediate |
| CN101985451B (en) * | 2010-11-02 | 2012-04-25 | 北京赛科药业有限责任公司 | Preparation method of prasugrel intermediate |
| CN102838618A (en) | 2011-06-22 | 2012-12-26 | 广东东阳光药业有限公司 | A method for preparing prasugrel and new crystal form of prasugrel hydrochloride |
| CN103694251B (en) * | 2014-01-06 | 2018-08-10 | 南京简成医药科技有限公司 | A kind of new process preparing prasugrel hydrochloride |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1074446A (en) * | 1991-09-09 | 1993-07-21 | 三共株式会社 | Hydroxypyridine Derivatives |
-
2008
- 2008-03-21 CN CN2008100349958A patent/CN101245072B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1074446A (en) * | 1991-09-09 | 1993-07-21 | 三共株式会社 | Hydroxypyridine Derivatives |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101245072A (en) | 2008-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101245072B (en) | Intermediates for the preparation of prasugrel and methods for their preparation | |
| CN101250193B (en) | Preparation method of 2-alkoxy-5-(α-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine | |
| CN101245073B (en) | Medicine intermediate and preparation method thereof | |
| CN106588747B (en) | A kind of synthetic method of aromatic ring simultaneously [a] carbazole compound | |
| CN103570696B (en) | A kind of preparation method of Axitinib intermediate and preparing the application in Axitinib | |
| CN104803956A (en) | Synthesis method of firocoxib | |
| CN101117332A (en) | Preparation method of 2-chloronicotinic acid | |
| CN101250192B (en) | Method for preparing 5-(alpha-cyclopropyl carbonyl-2-fluorobenzyl)-2-oxo-2,4,5,6,7,7a-hexahydrothiophene [3,2-c] pyridine | |
| CN105367427A (en) | Chiral 1,2-diamine compound and preparation method and application thereof | |
| CN103910671B (en) | The preparation method of Vismodegib and its intermediate | |
| CN104370935B (en) | A kind of preparation method of bisulfate clopidogrel | |
| CN110143941A (en) | A kind of synthetic method of Barrow Sa Weimabo ester intermediate | |
| CN103694251A (en) | Novel preparation process of prasugrel hydrochloride | |
| CN109678797A (en) | A method of quickly preparing ABA Receptor agonist | |
| CN101985451B (en) | Preparation method of prasugrel intermediate | |
| CN101220012B (en) | A method for synthesizing multiple substituted 4-fluoro-2(5H)-furanones | |
| Strayer et al. | In situ synthesis of 2-allyloxy-1-methylpyridinium triflate for the allylation of carboxylic acids | |
| CN106866707A (en) | A kind of preparation method of benzimidazole simultaneously [2,1 b] thiazole | |
| CN104496940B (en) | A kind of method for preparing BCR ABL inhibitor intermediates | |
| CN116003279B (en) | A kind of preparation method of green N-methylamide compound | |
| CN102225909B (en) | Preparation method of lansoprazole intermediate | |
| CN102002056B (en) | Preparation method of prasugrel intermediate | |
| CN102382165B (en) | Preparation method of dutasteride | |
| Layek et al. | A highly effective synthesis of 2-alkynyl-7-azaindoles: Pd/C-mediated alkynylation of heteroaryl halides in water | |
| CN104262236A (en) | Method for preparing corresponding pyridine compound from 1,4-dihydropyridine compound |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| DD01 | Delivery of document by public notice |
Addressee: Jie Wenxia Document name: Notification to Go Through Formalities of Registration |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110330 Termination date: 20170321 |